/C O R R E C T I O N -- Peregrine Pharmaceuticals, Inc./
Advertisement
In the news release, Peregrine (Nasdaq: PPHM) Reports Data ShowingBavituximab's Potential to Shrink Prostate Tumors, issued earlier today byPeregrine Pharmaceuticals, Inc. over PR Newswire, the headline should read"Peregrine Researchers Report Data Showing Bavituximab's Potential to ShrinkHuman Prostate Tumors in Model of Relapsed Disease" rather than "PeregrineReports Data Showing Bavituximab's Potential to Shrink Prostate Tumors" asincorrectly transmitted by PR Newswire.